Have a personal or library account? Click to login
Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) – Early Biomarker for Acute Kidney Injury in Critically Ill Patients Cover

Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) – Early Biomarker for Acute Kidney Injury in Critically Ill Patients

The Journal of Critical Care Medicine
Volume 1 (2015): Issue 4 (October 2015)
By: Grigorescu Bianca,  Fodor Raluca,  Mihaly Veres,  Monica Orlandea,  Judita Badea,  Katalin Hlavathy and  Adrian Cioc  
Open Access
|Nov 2015

References

  1. 1. Singbartl K, Kellum JA. AKI in the ICU: Definition, Epidemiology, Risk Stratification, and Outcomes. Kidney Int. 2012;81(9):819-25.10.1038/ki.2011.339
    Search in Google Scholar
  2. 2. Cruz DN, Cal M, Garzotto M. Plasma neutrophil gelatinaseassociated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2010; 36:444-51.10.1007/s00134-009-1711-1
    Search in Google Scholar
  3. 3. Fatemeh G, Faranak K, Esmat G, Rahimipour A, Houshang A, Malihe N. Assessment of Neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for detection of renal impairment in hypertensive patients. Journal of Paramedical Sciences. 2014;5:63-6.
    Search in Google Scholar
  4. 4. Flower DR, North AC, Sansom CE. The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta. 2000;1482:9-24.10.1016/S0167-4838(00)00148-5
    Search in Google Scholar
  5. 5. Bolignano D, Donato V, Coppolino G, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Kidney Damage.American Journal of Kidney Diseases. 2008;52:595-605.10.1053/j.ajkd.2008.01.020
    Search in Google Scholar
  6. 6. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425-32.10.1016/S0021-9258(18)82217-7
    Search in Google Scholar
  7. 7. Devarajan P: Emerging Biomarkers of Acute Kidney Injury. In Ronco C, Bellomo R, Kellum JA: Acute Kidney Injury. ContribNephrol, vol 156. Basel:Karger. 2007, pp 203-12.10.1159/00010208517464129
    Search in Google Scholar
  8. 8. K Mori, K Nakao. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney International. 2007;71:967-70.10.1038/sj.ki.500216517342180
    Search in Google Scholar
  9. 9. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.10.1186/cc5713220644617331245
    Search in Google Scholar
  10. 10. Prowle JR, Leitch A, Kirwan CJ, Forni LG. Positive fluid balance and AKI diagnosis: assessing the extent and duration of ‘creatinine dilution’. Intensive Care Med. 2015;41:160-1.10.1007/s00134-014-3538-725398305
    Search in Google Scholar
  11. 11. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): A new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;241:89-94.10.1080/00365510802150158252883918569973
    Search in Google Scholar
  12. 12. Perry TE, Muehlschlegel JD, Liu KY. Plasma Neutrophil Gelatinase-Associated Lipocalin and Acute Postoperative Kidney Injury in Adult Cardiac Surgical Patients. AnesthAnalg. 2010;110:1541-7.10.1213/ANE.0b013e3181da938e299984120435938
    Search in Google Scholar
  13. 13. Fielitz AH, Bellomo R, Devarajan P, et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant. 2009;24:3349-54.10.1093/ndt/gfp23419474273
    Search in Google Scholar
  14. 14. Bachorzewska GH, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. Neutrophil gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol. 2006;26:287-92.10.1159/00009396116772710
    Search in Google Scholar
  15. 15. Malyszko J, Bachorzewska GH, Malyszko JS, Dobrzycki S. Could NGAL predict renal function after percutaneous coronary interventions? J Am SocNephrol. 2006;17:406A.
    Search in Google Scholar
  16. 16. Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6:1639-45.10.1111/j.1600-6143.2006.01352.x16827865
    Search in Google Scholar
  17. 17. Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006;21:856-63.10.1007/s00467-006-0055-016528543
    Search in Google Scholar
  18. 18. Mitsnefes M, Kathman T, Mishra J, et al. Serum NGAL as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol. 2007;22:101-8.10.1007/s00467-006-0244-x17072653
    Search in Google Scholar
  19. 19. Bolignano D, Coppolino G, Campo S, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transpl. 2008;23:414-6.10.1093/ndt/gfm54117893105
    Search in Google Scholar
  20. 20. Bolignano D, Coppolino G, Campo S, et al. Neutrophil gelatinase associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol. 2007;27:373-8.10.1159/00010391217570904
    Search in Google Scholar
  21. 21. Legrand M, Jacquemod A, Gayat E. Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive Care Med. 2015;41:68-76.10.1007/s00134-014-3566-325465906
    Search in Google Scholar
  22. 22. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clinical Journal of the American Society of Nephrology. 2009;4:337-44.10.2215/CJN.03530708263760119176795
    Search in Google Scholar
  23. 23. Haase M, Bellomo R, Fielitz AH. Neutrophil gelatinaseassociated lipocalin: a superior biomarker for detection of subclinical acute kidney injury and poor prognosis. Biomarkers Med. 2011;5(4):415-7.10.2217/bmm.11.4921861662
    Search in Google Scholar
  24. 24. Devarajan P. Biomarkers for the early detection of acute kidney injury. Current Opinion in Pediatrics. 2011;23:194-200.10.1097/MOP.0b013e328343f4dd325751321252674
    Search in Google Scholar
  25. 25. Poniatowski B, Malyszko J, Bachorzewska GH, Malyszko JS, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res. 2009;32:77-80.10.1159/00020898919287180
    Search in Google Scholar
  26. 26. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 1996;38:414-20.10.1136/gut.38.3.41413830728675096
    Search in Google Scholar
DOI: https://doi.org/10.1515/jccm-2015-0023 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 154 - 161
Submitted on: May 2, 2015
|
Accepted on: Jul 5, 2015
|
Published on: Nov 10, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
NGAL,
AKI,
corrected creatinine,
critically ill patients
Related subjects:
Medicine,
Clinical medicine,
Anaesthesiology,
Emergency medicine and intensive-care medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other

© 2015 Grigorescu Bianca, Fodor Raluca, Mihaly Veres, Monica Orlandea, Judita Badea, Katalin Hlavathy, Adrian Cioc, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 1 (2015): Issue 4 (October 2015)Next article